Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109
...tibacterial activity against drug sensitive and both multi-drug resistant and extensively-drug resistant (MDR and XDR) Mycoba c terium tubercul o sis , the causative agent of tuberculosis (TB). The Phase 1B study will assess safety, pharmacokinetics and tolerability of multiple ascending doses of SQ...BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth
...s into the potential of beneficial microorganisms, known as specific probiotic cultures, to compensate imbalances in the microflora on a natural b a sis and restore the microbial equilibrium. In close cooperation with leading industry partners, OrganoBalance develops new biological products in the area...Global information firm reaches diverse markets
...formation, LLC (STI). John Deere purchased the sis for worldwide marketing and deployment in agricult... every year. It's been a straight shot up." The sis is now used in over 20 states, Europe, and North A...analysis stages." The DOD was interested in the sis to map and model battlefield areas. The goal was t...